Electrospun Poly (Vinylidene Fluoride-Co-Hexafluoropropylene) Nanofiber Membranes for Brine Treatment via Membrane Distillation

The major challenge for membrane distillation (MD) is the membrane wetting resistance induced by pollutants in the feed solution. The proposed solution for this issue was to fabricate membranes with hydrophobic properties. Hydrophobic electrospun poly (vinylidene fluoride-co-hexafluoropropylene) (PVDF-HFP) nanofiber membranes were produced for brine treatment using the direct-contact membrane distillation (DCMD) technique. These nanofiber membranes were prepared from three different polymeric solution compositions to study the effect of solvent composition on the electrospinning process. Furthermore, the effect of the polymer concentration was investigated by preparing polymeric solutions with three different polymer percentages: 6, 8, and 10%. All of the nanofiber membranes obtained from electrospinning were post-treated at varying temperatures. The effects of thickness, porosity, pore size, and liquid entry pressure (LEP) were studied. The hydrophobicity was determined using contact angle measurements, which were investigated using optical contact angle goniometry. The crystallinity and thermal properties were studied using DSC and XRD, while the functional groups were studied using FTIR. The morphological study was performed with AMF and described the roughness of nanofiber membranes. Finally, all of the nanofiber membranes had enough of a hydrophobic nature to be used in DCMD. A PVDF membrane filter disc and all nanofiber membranes were applied in DCMD to treat brine water. The resulting water flux and permeate water quality were compared, and it was discovered that all of the produced nanofiber membranes showed good behavior with varying water flux, but the salt rejection was greater than 90%. A membrane prepared from DMF/acetone 5-5 with 10% PVDF-HFP provided the perfect performance, with an average water flux of 44 kg.m−2.h−1 and salt rejection of 99.8%

Preparation and characterization of dextran-zein-curcumin nanoconjugate for enhancement of curcumin bioactivity

Curcumin is one of the most important polyphenolic nutrients in pharmaceutical industries. Unfortunately, its poor solubility and bioavailability have hampered its clinical application. To improve curcumin solubility and bioavailability, a natural nanocarrier made from protein-polysaccharide conjugate has been developed. Following antisolvent precipitation method, zein (Z) nanoparticles coated with dextran sulphate (DS) have been fabricated as curcumin (C) nanocarrier (DSZCNPs). The physicochemical properties of the nanoconjugate were measured using different techniques. Morphologically, DSZCNPs appeared spherical and monodispersed in scanning electron microscope (SEM) and transmission electron microscope (TEM) images. Curcumin encapsulation efficiency was ≈ 96%. DSZCNPs size was 180 nm and the polydispersity index value (PDI) 0.28. Zeta potential for DSZCNPs was −28.5 mV. DSZCNPs showed stability either for shelf storage (100 days) or at different pHs. Furthermore, DSZCNPs protected zein nanoparticles degradation in gastric environment and achieved controlled curcumin release in intestinal environment. DSZCNPs greatly enhanced the antioxidant activity of curcumin as demonstrated by DPPH assay. DSZCNPs had significant results in the reduction of colony forming unit (CFU%) against the tested microbes when compared with free curcumin. Also, the anticancer activity of DSZCNPs and free curcumin against hepatocellular carcinoma cells (HepG2) were assessed by MTT assay. IC50 for DSZCNPs was 13 µg/ml compared to 50 µg/ml for free curcumin indicating the therapeutic impact of DSZCNPs over free curcumin. Based on the above results, the developed zein-dextran nanocomplex exhibited high stability and improved the efficacy and bioactivity of curcumin suggesting its potential utility as nanovehicle for the hydrophobic drug curcumin.</p

Evaluation of a Hybrid Moving Bed Biofilm Membrane Bioreactor and a Direct Contact Membrane Distillation System for Purification of Industrial Wastewater

Integrated wastewater treatment processes are accepted as the best option for sustainable and unrestricted onsite water reuse. In this study, moving bed biofilm reactor (MBBR), membrane bioreactor (MBR), and direct contact membrane distillation (DCMD) treatment steps were integrated successively to obtain the combined advantages of these processes for industrial wastewater treatment. The MBBR step acts as the first step in the biological treatment and also mitigates foulant load on the MBR. Similarly, MBR acts as the second step in the biological treatment and serves as a pretreatment prior to the DCMD step. The latter acts as a final treatment to produce high-quality water. A laboratory scale integrated MBBR/MBR/DCMD experimental system was used for assessing the treatment efficiency of primary treated (PTIWW) and secondary treated (STIWW) industrial wastewater in terms of permeate water flux, effluent quality, and membrane fouling. The removal efficiency of total dissolved solids (TDS) and effluent permeate flux of the three-step process (MBBR/MBR/DCMD) were better than the two-step (MBR/DCMD) process. In the three-step process, the average removal efficiency of TDS was 99.85% and 98.16% when treating STIWW and PTIWW, respectively. While in the case of the two-step process, the average removal efficiency of TDS was 93.83% when treating STIWW. Similar trends were observed for effluent permeate flux values which were found, in the case of the three-step process, 62.6% higher than the two-step process, when treating STIWW in both cases. Moreover, the comparison of the quality of the effluents obtained with the analysed configurations with that obtained by Jeddah Industrial Wastewater Treatment Plant proved the higher performance of the proposed membrane processes

Immune System Evasion Mechanisms in Staphylococcus aureus: Current Understanding

Staphylococcus aureus is a major human pathogen that may cause a wide range of infections and is a frequent cause of soft tissue and bloodstream infections. It is a successful pathogen due to its collective virulence factors and its ability to evade the host immune systems. The review aims to highlight how S. aureus destroys and damage the host cells and explains how immune cells can respond to this pathogen. This review may also provide new insights that may be useful for developing new strategy for combating MRSA and its emerging clones such as community-associated methicillin-resistant S. aureus (CA-MRSA)